active weed and tech investor
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
No, he's still with Vireo. Just has a lot of pots on the fire.
https://www.prweb.com/releases/bruce_linton_to_discuss_his_next_great_adventure_at_cwcbexpo_new_york/prweb16943249.htm
Added 53% to my position at 0.625. Didn't expect this to drop like it did the past few weeks (obviously), but agree that Vireo is on the precipice of tremendous growth and positive market movement. The coronavirus scare has driven down the entire market, bringing weed with it (which was already cratering).
It's at a point now that valuations across the board are in line with standard companies in MUCH lower growth markets. Now it's just a matter of picking winners for the future. I am 100% confident that Vireo is one of those winners.
I Googled Howard Misle vs. State of California on Worker's Compensation Fraud and came up with nothing relevant. Provide a link.
Volume. It's all about volume.
People want vape pens. It's a huge market. They especially want vape pens that are based on high-quality weed, which Citation is all about. This news bodes well for CGOTF.
We are still in the throes of a cannabis slide...with Terra Tech and MedMen taking the brunt of the damage today (Terra Tech based on a bad reputation and MedMen based on bad numbers). But if history is any indication, January will see a turnaround. It could come even sooner as various legislative bills work their way through Congress to become law.
Added 4,000 shares today. Will add more if reaction to the quarterly report skews negative (reaction to virtually ALL reports nowadays is skewing negative, even when reports are positive). I'm 160,000+ shares strong today, including 36,000 bought at .26 a share.
Issues? Sure. Cannabis industry suffering overall? Sure. But this is a long-term play, not built for tomorrow's returns. When the industry calms down and level sets (long overdue, really), Citation will be among a handful of companies that bounce back with vigor.
And believe me, all the crappy companies will bounce back as well...just not as robustly as the smaller (and medium-sized) companies that have attractive fundamentals. There are fundamental reasons to be positive about Cresco, Trulieve, MariMed, Veritas Farms, Planet 13, Agritek, Pasha and more (and I've invested in all of those as they hit bottom here as well).
But Citation has a business model that is ripe for these times. Triple certified. Measured growth. Strategic shifting of assets. These all bode well for 2020... and even more for 2021 and beyond. That's what I'm focused on. Not next week or even next month. It's a three-year or longer strategy for me.
"Imminent" must mean two years, lol. What a joke. I expect we'll be hearing the same junk two years from now as well. And five, eight or fifteen years down the road. Thanks, but your credibility is already less than zero.
Citation News: Citation Advances Toward the Construction Completion of Company's First Cannabis Production Facility in British Columbia
https://finance.yahoo.com/news/citation-growth-corp-advances-toward-120000970.html?.tsrc=rss
Kelowna, British Columbia--(Newsfile Corp. - November 12, 2019) - Citation Growth Corp. (CSE: CGRO) (OTCQX: CGOTF) ("Citation" or the "Company"), a licensed cannabis cultivator and producer, announces that it has entered into an amended agreement (the "Amended Agreement") with 1186626 B.C. Ltd. ("1186626 ") in connection with its joint venture agreement (the "JV Agreement") on the Company's Celista property located in British Columbia (the "Celista Project").
Management has been resolute in their discovery of non-dilutive financing opportunities, in their commitment to maintain the integrity of the capital stricture. "We are very pleased with how this partnership has evolved. We have a big vision for this project, and are ready to move forward, full speed ahead, having the funding set in place." Stated, Rahim Mohamed, President. The Company is currently in the process of constructing the first two of ten buildings, totaling 100,000 square feet of cultivation and processing space at this project.
Pursuant to the JV Agreement, 1186626 was to provide a capital contribution in the aggregate amount of $10 million (the "Capital Contribution") to be delivered to the Company in four tranches of $2.5 million for the construction of ten 10,000 square foot cannabis production facilities. From the date of the agreement until the third year that all ten facilities are fully operational and in full production, project distributable cash flow (the "Project Distributable Cash") will be allocated as to 50% each to the Company and 1186626, and 100% to the Company thereafter.
Under the terms of the Amended Agreement, the Capital Contribution will be $6,350,000 (the "Amended Contribution) to finance the completion of the Company's 10,000 square foot facility, and the Project Distributable Cash has been amended as to 80% to 1186626 and 20% to the Company until the first year anniversary that 1186626's Amended Contribution has been fully repaid, and 100% to the Company thereafter.
All other terms and conditions of the JV Agreement remain the same.
In consideration of the Amended Agreement, the Company agreed to terminate its joint venture agreement with 1186626 with respect to the Chase property located in British Columbia. Additionally, further to the Company's press release dated April 22, 2019, the Company agreed to assign all of its right, title, interest in and to the Bud For You Inc. to 1186626.
Added another 4,000 shares yesterday, when the executive management had its little shake-up. Sometimes a shake-up causes a very temporary dip, as this one did. So I'm in for 7,000 shares at a .55 average. Still just a small stake, but I did a little more DD and find there's not all that much to hate about this company.
Sure, they're spending too much, and as Sasquatch625, DapperDan and others mention it seems they're hiding a bit of debt or expenses in their numbers, but you can't argue with the progress on income.
But everyone from Canopy to Cannabics is down 50% to 90% the past six months. I mean, almost no one has been immune. IMO, this makes for a great buying opportunity for those coming into the market, and Supreme is one of 10 companies I've invested about $40k into during the last couple weeks. I've lost money on Citation Growth in the past, but re-investing in the broader market makes sense right now.
Bottom line, I wouldn't put all your eggs into one basket (which is admittedly what I've done in the past). If you're already in Supreme, don't put more into it. Invest in CGC...or CGOTF (Citation), CRLBF (Cresco Labs), GRWG (GrowGeneration), ITHUF (iAnthus), MRMD (MariMed), PLNHF (Planet 13), TCNNF (Trulieve), or TRTC (Terra Tech).
The cannabis industry WILL rise from the ashes, folks. A few of the companies mentioned above have already stirred from their bottoms, unlike Supreme (yet). Others with good fundamentals, good growth, and without crippling debt or balance sheets are bound to bounce back. Take a look at https://www.newcannabisventures.com/cannabis-company-revenue-ranking/ and you'll find a slew of American and Canadian companies that are in the black (take a look at Adjusted Operating Income in the second-to-last column to find the healthy ones).
If you can't afford to diversify, I'd still sit tight with Supreme. There's too much good going on here to keep it down like this forever.
With the oversold collapse of the cannabis industry this year, I've been looking at companies to invest in because they are way undervalued. I've invested in 10 companies, including Cresco Labs, iAnthus Capital, GrowGeneration, MariMed, Supreme, and Trulieve. These are all pretty solid companies that have decent balance sheets (except iAnthus) and significant growth. I even have a little in CGC, as it seems everything is oversold.
But I particularly want to invest in companies that have a foothold in the US market, as the momentum for legalization and banking reforms seem to grow stronger. It's just a matter of time before some major things happen in the US market (I suspect it will happen after the 2020 elections no matter who wins).
I also like the way MedMed is growing, but the escalating losses are alarming. From a sales-to-price ratio perspective, MedMen is very attractive, but my God they are piling on the losses. Regardless of whether the private jets are real or imagined, the fact that employee compensation has skyrocketed is alarming.
Bottom line guys, if you're holding losses here, good luck. If you're new to this stock, this MIGHT be a good time to invest (anytime in the next couple weeks), but I wouldn't bet the house on this. It's a shame, because this company is huge and IS doing a lot of things right...but their rampant spending (mostly on themselves) is not doing anything good for shareholders. I might bet a little on it myself, but their shortsighted executive management prevents me from taking a much bigger position in MMNFF.
I just bought it. Just 3,000 shares, but this is among the cannabis companies that is most senselessly devalued. I will learn more as I consider buying more, but this seems like it's in the same boat as TRTC but without the leadership concerns at Terra Tech.
The question is, where will Supreme be at in 12 months? What will the company look like?
Where are all the shorts? Lord knows, when CGOTF was tanking for months, the longs were here, every single day, always willing to show up and make a case (led by LND2), but now that the shoe is on the other foot it seems they disappear. Ah well, good riddance.
Nearly 180,000 shares traded today. That's almost a good two weeks' volume in the past. Now it's just a matter of patience. Remember, a steady gradual upward pace is better than being up 100% in one day, because that will usually lead to being down 70% in the next week. Let the Citation story mature...let it percolate...let it spread. Citation WILL attract the buyers now that we have a foot in the door and the evidence has mounted far beyond hearsay.
More than anything, I am happy about the exponential rise in traded share volume. We've seen this rise before and then it sank back down, but I get a strong sense we will sustain the volume this time because of the positive, verifiable news that is coming out on a regular basis.
The share price is a bonus. In fact, the rise in price was inevitable given the rise in volume. You can't keep this company down. Shorts are still here, and you can literally see them at work today, fighting to drop the price, but because there are new buyers snatching up shares, it's a losing battle.
Frankly, if I were a short, I would be scared of this stock and I'd go away for quite a while. They are going to get their arse handed to them again and again in the coming months. On the flip side, the short dopes that stick around and have any impact on Citation's share price simply provide a buying opportunity for others to add more.
I'm still behind on my "play accounts" balances, but I've made over 25% in a couple weeks on 32,160 shares in my "real" retirement account. By the end of the year, I expect to be in a very calm state of mind knowing that our belief in the company has been justly rewarded.
In the broadest of terms, given a roughly $10M annual revenue, and utilizing a conservative P/S ratio of 12 (Aurora's current ratio is 20, which is normally way too high, but Aurora was at 80 just a few months ago and CGC is at 25 even today), Citation's market cap should be $120 million now. There are other $120M market caps in the cannabis industry that have similar revenue.
Given that Citation's market cap is currently $20M, a market cap of $120M would lead to a stock price of about US$1.93.
Other Comparisons:
Emerald (EMHTF) has a $100M cap and $8.3M revenue trailing 12 months (TTM) (P/S of 12)
Organigram (OGI) has a $550M cap and $75M revenue TTM (P/S of 7.4)
Green Organic Dutchman (TGODF) has a $236M cap and $8M revenue TTM (P/S of 59.5)
Tilray (TLRY) has a $2.4B cap and $94M revenue TTM (P/S of 25.5)
Given our licenses and potential for growth, you could easily give Citation a P/S ratio of 20, which would put us at a $200M market cap and $3.22 stock price.
Nah, doesn't make sense. MedMen (roughly three times bigger than TRTC) is nothing to be scared of. TRTC is a player and not gonna be so easily pushed off the stage.
So "TRTC will fizzle out" huh? That's a reach. Perhaps wishful thinking on your part.
In general, I agree with you and the article you linked. There's way too much pot. I've been out of CGC and the other bigwigs for quite some time and didn't suffer any losses there...but I've lost money on other smaller pot companies caught in the downdraft.
It's tempting to think of the weed industry like Amazon and online sales 10 years ago...that the growth is gargantuan and the right stock pick could make you rich. To some degree (if you got CGC three years ago and sold this past spring) it's held true, but weed was never going to be like online sales. It won't ever have that type of societal impact and change the way most people lead their lives on a day-to-day basis.
But regardless of Canadian pot-dumping, there is a case to be made for a bunch of smaller pot companies who have firmly established a market and are growing in a smart way. I know TRTC has NOT grown in a smart way, but they have, finally, after dropping 95+% in stock value over the last few years, reached an inflection point where the numbers almost can't be argued with.
Revenue of $40 million a year...or $60+ million as DP prefers it...that is sustainable can cover up for a lot of poor decisions in the past...or even in the future. The divestitures that they've made were strategic (best-case scenario) and set up the company with some financial stability and a potential pathway for future growth.
Just tell me...are the revenues going away? Is Terra Tech suddenly going to drop to $10M a year instead of $10M a quarter? Is Canada going to steal away their business?
If so, then I'm wrong. It won't kill me to be wrong (been wrong before). I haven't put my life savings into TRTC. But I bought TRTC for the first time ever today. My average price per share is .26. I'll make more investments in TRTC slowly over the course of the next six months, but it will never become a life-and-death thing for me, because I'm done riding one stock to fortune or famine. I just think this will be an interesting story to follow...and potentially a profitable one.
No, that does make sense. Don't try to catch a falling knife. That said, I look at the book-to-sales and related paradigms and decent recent sales growth and I don't see this going down a ton more, barring a disaster of some sort (and I can't rule that out).
I'm not saying Terra Tech is a perfect company by any means, but if what DP is trying to foist upon public investors has any truth (and again, it's in his best interests to spout some truth at this point), this turnaround in valuation will begin sometime in the next six months. And I just don't see it going from .25 down to .15 the way it went from .45 to .25.
A $28.6M market cap? With this revenue? Really? Yeah, I'll roll the dice on this one.
LOL, the cannabis sector has not failed. It has been devalued in a most spectacular way, but the "sector" is still a bull charging through a rapid growth period that will continue for years to come. This is truly the best of times to be seeking companies with good fundamentals, regardless of shorts or past problems.
The question is, can TRTC get rid of the bloat that plagues it? I'm guessing they can, with discipline and smart decisions...yeah, DP is not ideal for this job, but even he can get goals accomplished when they're in his best interest.
Yeah, this is the eighth of eight promissory notes that have been publicly known for a year and a half. The note "is the eighth of eight tranches of 7.5% Senior Convertible Promissory Notes to be issued by the Company to the Purchaser."
So, nothing new here and you're foolish to try to put this out as a new and unexpected debt. Instead, this is a cause for celebration because it marks the end of this toxic financing. It really establishes the beginning of the new TRTC (as new as it can get, anyway, with DP at the helm).
Nice article that provides a streamlined explanation of where Citation is and where they plan to go. It firmly establishes Citation's presence (no bankruptcy will be initiated here!) and offers solid evidence that it is undervalued in comparison to its peers.
More than ever, investors can see that Citation has developed a system for growing high-quality weed that can be replicated across the enterprise. It's just a matter of time, folks. Check our fundamentals and forward-looking revenue with other cannabis companies and you can see we have great upside potential today (our market cap is way too low) and even greater potential in the coming years as Citation's carefully laid-out plans come to fruition.
LND2 said he was averaged in at .38 on ONE of his accounts, not his entire holdings of CGOTF. I have 30,000+ shares in one of my accounts (my active 401k with a Brokerage Link on it) that is averaged in at .26! But that's dwarfed by my long-term holdings in my play accounts that are averaged in at over .80. I'm sure LND2 has an account or two where that is the case as well.
I agree with you isbizz, I wish I had gotten out of LIHT way earlier and then bought back in...but volumes were so tiny all year it would have taken too long to get out. But it does hurt to think I could have more than twice what I have today if I'd insisted on selling when the stock was over .80 earlier this year and then bought back in under .30. But .80 was what I was averaged in at and I wasn't selling until it was US$1.50 or higher, so I held. And I didn't think CGOTF would drop much below the .40 lows of last December (which I held all the way through), but then it nosedived well below that.
So...hindsight is 20/20. At least when it dropped below .30 and stayed there for months, I began buying it in my active 401k. That was high-risk for me, since that was money I REALLY cared about, but I just felt that under .30 was a bargain. And the CGOTF holdings in that account are still a small fraction of my 401k portfolio. So I felt I could roll the dice and average down my overall CGOTF holdings...and I'm so glad I did!
As every long will tell you, it's not a loser until you sell below what you bought it at. That's true, but it's also stupid. There comes a time, with some stocks, where you're just throwing money away. At one time, I was down nearly 80% with CGOTF in my play accounts. Since they were my "play" accounts, I had gotten to the point where I had almost written it off. I had played and lost.
But now I'm down less than 60% in my play accounts (still horrible, obviously, but better than where I was!) and behemoths like CGC are down more than 60% now. (BTW, I think CGC is finally a good buy again...they have the capital to sustain these losses and keep building.) Most importantly, more than ever before, I see CGOTF turning their whole story around. All this good stuff is borne from what I could see in the company a year ago when I began buying the stock. But now it's coming to fruition, and all the shorts talking about bankruptcy and lawsuits is laughably BS.
The shorts will never go away. But they are going to need a new story that at least has some semblance of truth. And isbizz, you can sell at .55 or .60 and claim you have doubled your money. Good for you. But LND2 and I know the potential of this company is much more than that. So pardon me when I don't listen to you when you let us "know when to dump it."
I'm going to keep playing with this one for a while....
The best news: volume is still not there. Sure, it's marginally better than what we've been getting most of the year. But there was a time last year when we were getting over 200,000 shares moved almost every day. You get THAT kind of volume...with sustained interest in what's really happening with TODAY's Citation...and $1.00 a share will be on our doorstep before you know it.
When people look at the history of Citation's chart, they'll see it commonly traded at ten times today's value without nearly the concrete evidence of good news, good revenue, and the potential for much greater revenue in the near future. Then it will seem like a bargain even at $3 or $4 a share...which is what LND2 and I were speculating about over a year ago.
Yes people, while dreams may have been delayed...they may finally be coming to fruition. As always, it's always been dependent on a large volume of shares being bought and sold. As Citation becomes a brand that can no longer be ignored, the interest in getting in on the party will lead to real celebration.
External News Coverage of Triple Certified Citation
https://potstocknews.com/citation-growth-corp/cgro-2/trust-in-vaping-only-one-company-is-producing-the-safest-most-organic/LP-ML?utm_source=Barchart&utm_medium=email&utm_campaign=email_CGRO_Barchart_LP-Erode-trust-PSN_cmt_CA-US_NA_504046
Yes, this is no doubt linked to PR put out by the company, but this is exactly the type of media coverage we need. This will help spread the word. I like how it has a dozen links throughout (and at the end of) the article that document what they're writing about.
Indeed, this rapidly expanding boat is never returning to the old docks again. Sail on!
Citation remains a bargain under 40 cents a share, so while volume remains a problem, value should not. I will continue dollar-cost-averaging into more shares at least once a month as long as it's under 40 cents. After multiple misdeeds, missed calls, and missed opportunities, once again Citation (under current leadership) appears to be gaining steam...and this time the boat may never return to its old docks.
Alert me when it gets to $0.75. Then I'll have a profit, lol. Yes, any bump is a good bump, but this has a long way to go.
I generally agree with you about gummies. Although I will say, that's exactly how I ingested at S.D. Comic Con a few years ago. Man that stuff got me high. But it was an enjoyable way to get there. Still, they (legal authorities and lawmakers) should outlaw certain forms of ingestibles that are most appealing to kids and teens. What about lollipops? THC lollipops are very popular among adults as well.
I do think the pot manufacturers need something that takes time to ingest, like lollipops (jawbreakers or something), as it might help people monitor their intake. Gummies seem very targeted to the young. Maybe throwback candies like black licorice Twizzlers, candy canes or Necco wafers? LOL, the kids wouldn't like Necco wafers! Acquired taste!
I will say this about volume. I have complained many times in the past about the lack of volume. On the other hand, the price fluctuations in the past several months have certainly been exacerbated by the lack of interest in CGOTF. This means that when the real investors are away, the mice will play.
The question is, when will the real investors return to this stock and chase the mice away? It will take more than a press release or two by Citation. It will take major news from media outside of the company. That could happen next week...or next year. But for me it appears the company is stable enough to forge on indefinitely, despite all the squeaks from the mice.
Yeah, I added 4,150 shares today. Could not resist at these prices. I keep averaging down. 156,000+ shares and willing to keep going a little bit at a time. This company has ENOUGH going for it that it is significantly undervalued at these prices.
LND2, send me contact information via PM. I can't PM without a subscription, and I would not subscribe to a board that does this little to properly supervise its moderators.
Nothing has changed!
Yes, I am crazy. Bear in mind, most of my holdings are in my "play" accounts, except for the last 22,600 shares, which I acquired in my "real" retirement account. But my play accounts are for speculation...and this particular speculation was mis-timed 8-10 months ago, but that doesn't mean it won't eventually pay off.
Getting shares now at a 65% discount to where I got most of my shares means, of course, that I'm averaging down. The experts say don't do that (again, good money after bad), but I still see the potential here...as delayed as it has been. I don't know, it just feels right to get in at this level and it's comforting to average down...I will probably get some more if it stays at these levels or goes further down.
All of that said, I hold $300k of physical gold and silver and have seen that go up $50k in the last three months, so I'm not crying in my beer. Then there's my other "real" holdings and my house equity and various collectibles ($150k easy from that alone), so I'm hardly betting the farm on Citation. But it has still been painful to see $75k disappear from being stubborn...which I am.
Not much I can do with the losses I've suffered already, but there's no reason not to throw good money after bad (LOL), so in the past couple weeks I've added 22,600 shares at an average of 28 US cents. With a market cap of $16.7 million, it's almost inconceivable that Citation could drop much lower...but there are some worthless companies worth $1.6 million so you never know. But Citation is clearly not worthless, despite what others blather on about.
In other words, I'm still in. I hold more than 147,000 shares (haha, about two weeks worth of volume the way things have been going). There was a time when LND projected $2.00 by the end of THIS year ($8.00 now, post-split) and much higher down the road and I was "conservatively" projecting $6.00 post-split this year. Currently, these are all laughable projections but there is something to be said for being patient if the company has competitive advantages...and Citation still does have some of those.
Long-time holder, and I'm disgusted by the lack of communication and action by Citation Growth's executive committee. My investment is in my "play" accounts and I don't count on it too much, but I've lost over 65% and $70,000 (in six months!) by hanging on. Not much to do but wait it out, but the utter lack of trade volume is exactly what I've been whining about for months.
I don't want to hear about a takeover or a merger or other pie-in-the-sky projections. These are meaningless. If THAT is your claim to shareholder value, you are sadly lost in false hope. Could a takeover happen? Of course. But even if it does, I'd be lucky to get half my losses back. And chances are far better that there will be no takeover at all. Pinning your hopes on Rivera being "planted" at Citation because a takeover is being planned is pinning your hopes on a pipe dream. If it happens, lord knows you'll get credit for predicting it, but stop talking about it.
The company needs to demonstrate certifiable value by growing reported revenue and profits and executing on announced expansion plans. Anything less means nothing. And they have done a terrible job of that so far. I was optimistic just six months ago. Now I'm just nauseous.
I saw that website yesterday. Man, it's really ugly. The logo looks like it's from the 1980s or something. Jeez, they could use a graphic designer.
No, AMMJ (American Cannabis Company) does go by ACC when referring to themselves, but they are a smaller company. They're also ambitious, but are in earlier stages of expansion. The "ACC Group of Companies" mentioned in the news release is a bit of an enigma to me and I don't know anything about them, but they're not AMMJ. There's a whole different set of names and brands associated with the ACC that Liht is working with.
One thing is for sure: Liht, soon to be Citation Growth, can shake things up on a regular basis. It will be very interesting to see how this plays out in the coming weeks and months.
The moderators for this board have their work cut out for them, too, as so much of the news and facts that precede this message board are changing in a big way.
I will say this: the Liht team has extremely high ambitions and if ambition is measured in the stock price, we'll see rapid growth. On the other hand, it seems like there is a heck of a lot of dilution coming down the pike.
Where will all this end up in two or three years?
That's very good news indeed. Not sure it was worth halting trading, but we shall see. Just one more step forward in the long, profitable journey for Liht.
I am hopeful of good news. It's been a while since I posted (just imagine why) but I still hold all half-million shares. I was fine with LIHT dribbling along at 19-22 cents but seeing it go down to 16 and then 14 has been discouraging. My lament is like a broken record: volume. Without it, we're screwed.
But I still believe in the upside. Not so sure about a partnership, but with today's trading halt I am intrigued. I was willing to stick it out through at least October to make my holdings a long-term gain, but of course it could also be a loss (I'm in at an average slightly below 22 cents). Hope to celebrate with the other longs when our ship finally sails in.
If Aurora/Australis legitimately stepped in to partner with Liht on Vegas as a publicly identified cohort and it was announced that their capital would be used to immediately fund an expansion to a 300,000 sq. ft. site (or more likely the 65,000 sq. ft. "phase two" of Vegas operations), of course LIHTF would skyrocket. The devil would be in the details of the partnership, but naturally any influx of capital like that, especially associated with a name like Aurora, would boost LIHTF much higher.
How high? Who knows? Certainly above 50 cents! I would presume above $1.00 and potentially much higher, especially if there was talk about what they planned to do in Canada as well. Doubtlessly the stock price would attain such a level and then back off 20-30% after the initial euphoria subsided...but then could edge up ever higher as things begin to happen.
But every decent stock expert from Jim Cramer on up tells you it's a terrible idea to invest in a company based on a future buyout or partnership. It's an area fraught with pitfalls and a waiting game for something that most likely will never happen.
That said, the odds of a buyout or a partnership with Liht are literally 1,000 times better than with other small companies. There are several signs of a potential deal, which you have cited, and the one I'm most keen on is Nilda Rivera. Presuming she left on good terms with Aurora (or didn't actually "leave" in the truest sense of the word, as you suggested), she might well have come to Liht to help orchestrate a partnership with Australis. Making that kind of assumption is not far-fetched at all. It's also possible that Liht's selling of the rights to other locations and properties were not entirely internally directed, but guided by Rivera's knowledge of what Australis wanted to happen prior to a business engagement.
I would simply caution that these things often take time and move slower than anticipated. Yes, something could happen tomorrow or next month, but even if Nilda was placed at Liht for a partnership reason, it could still take a year or more before they're ready to make the move. Not that Liht wouldn't grow on its own in that time, which would make a future partnership that much better for LIHTF stockholders.
Like I said, I see the story in the next five or six months one of Liht growing exponentially anyway, leading up to a quarterly announcement in September that really puts us on the map. Of course I would welcome a significant partnership with someone who could accelerate all of our plans in a much quicker way. And I wouldn't be bummed out if it happened soon. We certainly need an influx not only of capital, but energy and verifiable progress, which would give us an exponential leap in market exposure, which is my number-one concern.
I agree that TCH levels are not the only desirable attributes for weed, but they are a good way for Liht to make a name for themselves. They're also a good way to get into stores...who want to be able to tout that they proudly carry triple certified, highest-THC level marijuana. There's no doubt that this weed will garner the highest possible wholesale price.
My concerns haven't changed over time, so I won't drone on again about them here. I know that "discovery" will quickly lead to higher share volume and thereby higher PPS, easily eclipsing 20 cents when we need it most. But I was hoping that same scenario would have us easily eclipsing 30 cents, not 20 cents. But over the course of the next five or six months, I do expect that good news will quickly elevate...and SUSTAIN...higher prices.
But LND2, you have to admit that your share price predictions for this calendar year are overly optimistic. I am more conservative-thinking than you and even I was hoping to bust $1.00 a share this year. Now I'd be extremely impressed with 50 cents a share...and that's with at least SOME verifiable news on business expansion.
Still happy with where I am. Still not going anywhere.